Intelligence Artificielle
Ophtalmologie
Santé numérique
Recherche scientifique
Innovation
500000 +
About Our Vision
L’intelligence artificielle au service de la santé visuelle, pour un impact à grande échelle
- AI-Assisted Early Detection
- Intelligent Retinal Image Analysis
- Tools Designed for Real Clinical Environments
- Scientifically Validated Algorithms Supervised by Humans
- Clear and Actionable Diagnostic Reports
- Collaboration with Leading Hospital and University Centers
- Strict Compliance with International Medical and Regulatory Standards
- Continuous Medical, Technical, and Scientific Support
Why Choose DIAGNOS?
L’intelligence artificielle au service d’une vision préservée, à grande échelle
Un dépistage intelligent, rapide et non invasif, adapté aux pratiques réelles
Un dépistage intelligent, rapide et non invasif, adapté aux pratiques réelles
Equipped Centers
Eye Images Analyzed
Medical Partnerships
Validated Studies / Awards
Ecosystem
- Media center
- Clinical research

Media center
DIAGNOS has been featured in a range of specialized media outlets, business publications, and health programs. Below is a selection of recent media coverage- Le Devoir — “DIAGNOS and ÉTS announce over $1 million in federal funding to drive innovation in next-generation retinal AI.”
- Radio-Canada / ICI Gaspésie — Coverage of the deployment of DIAGNOS’ AI-assisted diabetic retinopathy screening across the CISSS de la Gaspésie network
- La Presse (Innovation Special Report) — DIAGNOS featured as a Quebec leader in the application of AI to medical diagnosis (FLAIRE platform)

Strategic partnerships and clinical research
DIAGNOS relies on close collaborations with leading clinical centers and top-tier academic institutions around the world. It is through this constant dialogue between real-world practice and research that we anchor the scientific rigor of our retinal imaging analyses. Our publications document the accuracy and reproducibility of our work, with a clear ambition: to enable earlier detection and more rigorous follow-up, as close as possible to real clinical practice- Early detection and emerging signals
- Multicenter validation in real-world settings
- Tracking the progression of retinal conditions
- Analytical precision and reproducibility
Investor area
- Press releases
- Stock market and financial information
- Resource center
DIAGNOS is committed to maintaining an ongoing and transparent dialogue with all of its stakeholders. More than a simple flow of information, our press releases serve as the official record of our strategic deployment and our contribution to global health. Each announcement marks a meaningful step in advancing our mission, reflecting both the strength of our business model and our ability to translate technological innovation into tangible clinical value
- Strategic Partnerships & Clinical Deployment: Announcements related to partnerships with hospital networks, specialized clinics, and major distribution players on an international scale
- Geographic Expansion & Licensing: Updates on our progress in new global markets and the securing of operating licenses from health authorities
- Technological Innovation: Highlights of critical advances in the development of our next-generation algorithms and the outcomes of our clinical validation efforts
- Institutional Recognition: Showcasing major government support, industry recognition, and our participation in leading-edge research initiatives
DIAGNOS is committed to upholding the highest standards of financial transparency and corporate governance. As a public company, we provide markets and shareholders with the tools they need to monitor their investment in a rigorous and compliant manner
- Listings and stock exchanges: Ongoing information on our activities on the TSX Venture Exchange (ADK) and the OTCQB (DGNOF). We ensure the disclosure of regulatory information in accordance with the requirements of the relevant authorities
- Tax compliance and forms: Access to the official tax documents required for security holders, including IRS Form 8937 for U.S. investors, ensuring compliance with international tax obligations
The Resource Center brings together all of DIAGNOS’ institutional and regulatory documentation in one place. It serves as a reference library for investors, analysts, and partners seeking a deeper understanding of the company and its operating framework
- Press Release Archive
- Annual Reports, Consolidated Financial Statements
- Stock market and financial information
Management Team
André Larente
President - Director
Yves-Stéphane Couture
Chief Operating Officer
Marc-André Massue
Chief Financial Officer
Dr Hadi Chakor
Chief Medical Officer (CMO)
Dr Ismail Ben Ayed
Chief Scientist, Artificial Intelligence
Silvain Bériault, PhD
Director of Software Development
Our team
Board of Directors
Philippe Couillard
Chairman of the Board of Directors and Director
André Larente
President - Director
Michael Braeuel
Director
Robert Dunn
Director
Our team
Advisory Council
Ed Weiner
Advisor
Dr Tomas J. Philipson
Advisor
Dr Barry Ginsberg
Advisor
Dr Pierre-Luc Charlebois
Advisor
Besoin d'une solution d’IA pour le dépistage oculaire ?
Contactez DIAGNOS — nos équipes vous accompagnent
Portfolio
Projets IA & Innovations
Avis & retours
Ce qu’ils disent de nous
I would recommend practitioners at this center to everyone! They are great to work with and are excellemt trainers. Thank you all!

Maria Flynn
I would recommend practitioners at this center to everyone! They are great to work with and are excellemt trainers. Thank you all!

Jennifer Smith
I would recommend practitioners at this center to everyone! They are great to work with and are excellemt trainers. Thank you all!

Jane Brown
I would recommend practitioners at this center to everyone! They are great to work with and are excellemt trainers. Thank you all!

Becky Linch
I would recommend practitioners at this center to everyone! They are great to work with and are excellemt trainers. Thank you all!

Daniel Craig
I would recommend practitioners at this center to everyone! They are great to work with and are excellemt trainers. Thank you all!

Mariam Ness
Contact
Contactez-nous
Contact
Contactez-nous
Client-07


Client-06


Client-05


Client-04


Client-03


Client-02






